Fecal Microbiota Transplantation Combined with Prebiotics Ameliorates Ulcerative Colitis in Mice
Future Microbiology · 2023-11 · 18 (17) · 1251-1263
DOI: 10.2217/fmb-2023-0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Microbiology, online erschienen am 13.10.2023. Verfasst von Xueyi Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine Center, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, 241001, China. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Colitis, Ulcerative. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: outstanding young talents in colleges and universities of Anhui Province.
Abstract (Originalsprache)
Aim
To investigate the effect of treatment with fecal microbiota transplantation (FMT) and galacto- and fructo-oligosaccharides on ulcerative colitis (UC) in mice. Materials & methods: A total of 90 mice, divided into nine groups, were administered FMT or prebiotics or combined treatment. The disease activity index scores, gut microbiota and inflammation factors were evaluated.
Results
The treatment using FMT combined with galacto- and fructo-oligosaccharides in a 9:1 ratio significantly reduced intestinal barrier damage and alleviated symptoms of UC. Lactobacillus and Bifidobacterium and short-chain fatty acids were significantly increased after the combined treatment.
Conclusion
The results demonstrate that FMT with prebiotics is a new method for UC treatment. Changes in the bacteria that live in the human gut can cause ulcerative colitis, a type of inflammatory disease in the bowel. Using mice, we investigated two possible treatments for ulcerative colitis: fecal microbiota transplantation, in which a sample of feces is taken from a healthy donor, processed and transferred to someone else; and prebiotics, a nondigestible food ingredient that encourages the growth of good bacteria in the gut. We found that the combination of prebiotics with fecal microbiota transplantation can improve symptoms and change the bacteria in the intestines and improves the uptake of nutrients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Precision Medicine Center, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, 241001, China.
- School of Pharmacy, Wannan Medical College, Wuhu, Anhui Province, 241002, China.
- Department of Gastroenterology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, 241001, China.
ORCID-Profile: Xueyi Qian, Yuliang Jia, Zhenyu Xu
Förderung
- outstanding young talents in colleges and universities of Anhui Province
Zitieren
APA
Qian, X., Jiang, H., Wu, Y., Shao, H., He, W., He, Y., Bao, X., He, L., Jia, Y., & Xu, Z. (2023). Fecal Microbiota Transplantation Combined with Prebiotics Ameliorates Ulcerative Colitis in Mice. Future Microbiology, 18(17), 1251-1263. https://doi.org/10.2217/fmb-2023-0001
Vancouver
Qian X, Jiang H, Wu Y, Shao H, He W, He Y, et al. Fecal Microbiota Transplantation Combined with Prebiotics Ameliorates Ulcerative Colitis in Mice. Future Microbiology. 2023;18(17):1251-1263. doi:10.2217/fmb-2023-0001
BibTeX
@article{Qian2023,
author = {Qian, Xueyi and Jiang, Hua and Wu, Yao and Shao, Huimin and He, Weijie and He, Yinmei and Bao, Xin and He, Lianjun and Jia, Yuliang and Xu, Zhenyu},
title = {Fecal Microbiota Transplantation Combined with Prebiotics Ameliorates Ulcerative Colitis in Mice},
journal = {Future Microbiology},
year = {2023},
volume = {18},
number = {17},
pages = {1251--1263},
doi = {10.2217/fmb-2023-0001}
}
EUVIMED